Identification of mutations in the PYRIN-containing NLR genes (NLRP) in head and neck squamous cell carcinoma

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Lei, Yu ^a   Lui, Vivian W Y ^b   Grandis, Jennifer R ^b,c   Egloff, Ann Marie ^b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; LEUCINE; NLRP PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CELL; CARCINOGENESIS; CHROMOSOME 11P; CHROMOSOME 19Q; CLINICAL FEATURE; FEMALE; FISHER EXACT TEST; GENE; GENE CLUSTER; GENE IDENTIFICATION; GENE LOCATION; GENE MUTATION; GENETIC ASSOCIATION; GENOMIC INSTABILITY; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIGENE FAMILY; MUTATION RATE; NLRP GENE; PRIMARY TUMOR; RANK SUM TEST;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 19; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC HETEROGENEITY; GENOMIC INSTABILITY; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MOUTH FLOOR; MUTATION; NEOPLASM STAGING; SURVIVAL ANALYSIS;

EID: 84900550219     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0085619     Document Type: Article

References (40)

1. Nik-Zainal S, Alexandrov LB, Wedge DC, Van Loo P, Greenman CD, et al. (2012) Mutational processes molding the genomes of 21 breast cancers. Cell 149: 979-993.
2. Nik-Zainal S, Van Loo P, Wedge DC, Alexandrov LB, Greenman CD, et al. (2012) The life history of 21 breast cancers. Cell 149: 994-1007.
3. Hanahan D,Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144: 646-674.
4. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917.
5. van Monsjou HS, Balm AJ, van den Brekel MM, Wreesmann VB (2010) Oropharyngeal squamous cell carcinoma: a unique disease on the rise? Oral Oncol 46: 780-785.
6. Stransky N, Egloff AM, Tward AD, Kostic AD, Cibulskis K, et al. (2011) The mutational landscape of head and neck squamous cell carcinoma. Science 333: 1157-1160.
7. Agrawal N, Frederick MJ, Pickering CR, Bettegowda C, Chang K, et al. (2011) Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science 333: 1154-1157.
8. Ting JP, Lovering RC, Alnemri ES, Bertin J, Boss JM, et al. (2008) The NLR gene family: a standard nomenclature. Immunity 28: 285-287. (Pubitemid 351350631)
9. Davis BK, Wen H, Ting JP (2011) The Inflammasome NLRs in Immunity, Inflammation, and Associated Diseases. Annu Rev Immunol.
10. Ting JP, Duncan JA, Lei Y (2010) How the noninflammasome NLRs function in the innate immune system. Science 327: 286-290.
11. Ting JP, Willingham SB, Bergstralh DT (2008) NLRs at the intersection of cell death and immunity. Nat Rev Immunol 8: 372-379. (Pubitemid 351596409)
12. Lamkanfi M, Dixit VM (2009) Inflammasomes: guardians of cytosolic sanctity. Immunol Rev 227: 95-105.
13. Lei Y, Wen H, Yu Y, Taxman DJ, Zhang L, et al. (2012) The mitochondrial proteins NLRX1 and TUFM form a complex that regulates type I interferon and autophagy. Immunity 36: 933-946.
14. Cooney R, Baker J, Brain O, Danis B, Pichulik T, et al. (2010) NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation. Nat Med 16: 90-97.
15. Jounai N, Kobiyama K, Shiina M, Ogata K, Ishii KJ, et al. (2011) NLRP4 negatively regulates autophagic processes through an association with beclin1. J Immunol 186: 1646-1655.
16. Lei Y, Wen H, Ting JP (2013) The NLR protein, NLRX1, and its partner, TUFM, reduce type I interferon, and enhance autophagy. Autophagy 9: 432-433.
17. Zaki MH, Vogel P, Malireddi RK, Body-Malapel M, Anand PK, et al. (2011) The NOD-like receptor NLRP12 attenuates colon inflammation and tumorigenesis. Cancer Cell 20: 649-660.
18. Allen IC, Wilson JE, Schneider M, Lich JD, Roberts RA, et al. (2012) NLRP12 suppresses colon inflammation and tumorigenesis through the negative regulation of noncanonical NF-kappaB signaling. Immunity 36: 742-754.
19. Allen IC, TeKippe EM, Woodford RM, Uronis JM, Holl EK, et al. (2010) The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer. J Exp Med 207: 1045-1056.
20. Zaki MH, Lamkanfi M, Kanneganti TD (2011) The Nlrp3 inflammasome: contributions to intestinal homeostasis. Trends Immunol 32: 171-179.
21. Chen GY, Liu M, Wang F, Bertin J, Nunez G (2011) A functional role for Nlrp6 in intestinal inflammation and tumorigenesis. J Immunol 186: 7187-7194.
22. Elinav E, Strowig T, Kau AL, Henao-Mejia J, Thaiss CA, et al. (2011) NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 145: 745-757.
23. Normand S, Delanoye-Crespin A, Bressenot A, Huot L, Grandjean T, et al. (2011) Nod-like receptor pyrin domain-containing protein 6 (NLRP6) controls epithelial self-renewal and colorectal carcinogenesis upon injury. Proc Natl Acad Sci U S A 108: 9601-9606.
24. Strowig T, Henao-Mejia J, Elinav E, Flavell R (2012) Inflammasomes in health and disease. Nature 481: 278-286.
25. Zaki MH, Vogel P, Body-Malapel M, Lamkanfi M, Kanneganti TD (2010) IL-18 production downstream of the Nlrp3 inflammasome confers protection against colorectal tumor formation. J Immunol 185: 4912-4920.
26. Meyer E, Lim D, Pasha S, Tee LJ, Rahman F, et al. (2009) Germline mutation in NLRP2 (NALP2) in a familial imprinting disorder (Beckwith-Wiedemann Syndrome). PLoS Genet 5: e1000423.
27. Slim R, Coullin P, Diatta AL, Chebaro W, Courtin D, et al. (2012) NLRP7 and the genetics of post-molar choriocarcinomas in Senegal. Mol Hum Reprod 18: 52-56.
28. Ahn J, Chen CY, Hayes RB (2012) Oral microbiome and oral and gastrointestinal cancer risk. Cancer Causes Control 23: 399-404.
29. Meyer MS, Joshipura K, Giovannucci E, Michaud DS (2008) A review of the relationship between tooth loss, periodontal disease, and cancer. Cancer Causes Control 19: 895-907.
30. Meurman JH (2010) Oral microbiota and cancer. J Oral Microbiol 2.
31. Mashberg A, Samit A (1995) Early diagnosis of asymptomatic oral and oropharyngeal squamous cancers. CA Cancer J Clin 45: 328-351.
32. Neville BW, Day TA (2002) Oral cancer and precancerous lesions. CA Cancer J Clin 52: 195-215.
33. Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, et al. (2010) Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 363: 24-35.
34. O'Rorke MA, Ellison MV, Murray LJ, Moran M, James J, et al. (2012) Human papillomavirus related head and neck cancer survival: A systematic review and meta-analysis. Oral Oncol.
35. Moore CB, Bergstralh DT, Duncan JA, Lei Y, Morrison TE, et al. (2008) NLRX1 is a regulator of mitochondrial antiviral immunity. Nature 451: 573-577. (Pubitemid 351186265)
36. Woods KV, El-Naggar A, Clayman GL, Grimm EA (1998) Variable expression of cytokines in human head and neck squamous cell carcinoma cell lines and consistent expression in surgical specimens. Cancer Res 58: 3132-3141. (Pubitemid 28335097)
37. Pries R, Wollenberg B (2006) Cytokines in head and neck cancer. Cytokine Growth Factor Rev 17: 141-146. (Pubitemid 43949076)
38. Brailo V, Vucicevic-Boras V, Lukac J, Biocina-Lukenda D, Zilic-Alajbeg I, et al. (2011) Salivary and serum interleukin 1 beta, interleukin 6 and tumor necrosis factor alpha in patients with leukoplakia and oral cancer. Med Oral Patol Oral Cir Bucal.
39. White E (2012) Deconvoluting the context-dependent role for autophagy in cancer. Nat Rev Cancer 12: 401-410.
40. Collisson EA, Cho RJ, Gray JW (2012) What are we learning from the cancer genome? Nat Rev Clin Oncol.